Verily Health Inc.
Last verified 2026-05-07. JSON
| Total raised | $3.7B |
|---|---|
| Latest round | Funding round, $300.0M, 2026-03-18 |
| Founded | 2015 |
| Headquarters | Dallas, TX |
| Industry | technology |
| Stage | unknown |
| Website | verily.com |
Verily is an Alphabet life-sciences company offering precision-health software, real-world evidence platforms, and a stoma-and-glucose continuous-monitoring product line. Customers include pharma, providers, and health systems running real-world studies and risk-bearing programs. Verily operates Project Baseline cohort research alongside commercial software.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-18 | Funding round | $300.0M | undisclosed |
Detected tech stack
Vercel, Google Tag Manager, Intellimize, React, Webpack, next.js
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $300.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $3.7B | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | verily.com, read 2026-05-07 |
| Description | self-reported | verily.com, read 2026-05-07 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $300.0M, 2026-03-18 → Funding round, $300.0M, 2026-03-18, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $300.0M, 2026-03-18 → Funding round, $300.0M, 2026-03-18 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes